Skip to main content

Table 1 Data for 7 male patients (age range from 47 to 73 years) who underwent transperineal cryotherapy for high grade MIBC

From: Transperineal cryotherapy for unresectable muscle invasive bladder cancer: preliminary experience with 7 male patients

Patients

TLD(cm)

OP(min)

PFS(month)

Location

Initial symptom

Complications

Post-cryosurgery

Additional Treatment

1

7.5

55

11

Left wall

Hematuria

None

Chemoradiotherapy

2

8.3

70

25

Left wall

Urinary irritation

Urinary irritation

Chemoradiotherapy

3

6.5

50

35

Left wall

Hematuria, Urinary

irritation, Abdominal

pain

Abdominal

pain

Chemotherapy

4

11.4

120

3

Right wall

Hematuria

None

None

5

8.1

100

40

Left wall

Hematuria, Abdominal pain

None

Chemoradiotherapy

6

5.8

75

8

Back wall

Hematuria

None

Chemoradiotherapy

7

7.5

65

32

Right wall

Hematuria, Urinary

irritation

None

Chemoradiotherapy

  1. Note: TLD tumor longest diameter, PFS progression free survival, OP operation time